Cyclacel Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company. It uses cell cycle, transcriptional regulation and DNA damage response biology to develop medicines for cancer and other proliferative diseases. The company builds a biopharmaceutical business, which is focused in hematology and oncology based on a pipeline of novel drug candidates. Its products include CYC065, seliciclib, and sapacitabine. The company was founded by Ronald J. Berenson, David Philip Lane, and David Glover on August 13, 1996 and is headquartered in Berkeley Heights, NJ.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
N/A
Frequently Asked Questions
What is the 52-week high for Cyclacel Pharmaceuticals Inc - 6% PRF PERPETUAL USD 10?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Cyclacel Pharmaceuticals Inc - 6% PRF PERPETUAL USD 10 52 week high is $22.20 as of April 26, 2024.
What is the 52-week low for Cyclacel Pharmaceuticals Inc - 6% PRF PERPETUAL USD 10?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Cyclacel Pharmaceuticals Inc - 6% PRF PERPETUAL USD 10 52 week low is $5.25 as of April 26, 2024.
What is Cyclacel Pharmaceuticals Inc - 6% PRF PERPETUAL USD 10 stock price today?
What is the 50-day moving average of Cyclacel Pharmaceuticals Inc - 6% PRF PERPETUAL USD 10?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Cyclacel Pharmaceuticals Inc - 6% PRF PERPETUAL USD 10 50-day moving average is $17.62.